Zobrazeno 1 - 10
of 371
pro vyhledávání: '"JIN HYOUNG KANG"'
Autor:
Der Sheng Sun, Yoon Ho Ko, Jong Youl Jin, In Sook Woo, Suk Young Park, Yun Ae Eom, Jin Hyoung Kang, Hoon Kyo Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 3, Pp 406-416 (2023)
Background/Aims We compared the efficacy of the granisetron transdermal system (GTS) with that of ondansetron for controlling chemotherapy-induced nausea and vomiting (CINV) in patients treated with highly emetogenic chemotherapy (HEC). Methods We ra
Externí odkaz:
https://doaj.org/article/6cbaec29d6c3464081c63bf2848ce1b1
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Purpose Rapid development of novel therapeutics in renal cell carcinoma (RCC) has led to financial burden for patients and society. Value including clinical benefit, toxicity affecting quality of life and cost-effectiveness are a concern, pr
Externí odkaz:
https://doaj.org/article/5ebb2c7cee7447a9a69e3a5b75c0ca62
Autor:
Seo Ree Kim, Sang Hoon Chun, Joo Ri Kim, Sang-Yeob Kim, Jun Young Seo, Chan Kwon Jung, Bo-Mi Gil, Jeong-Oh Kim, Yoon Ho Ko, In Sook Woo, Byoung Yong Shim, Sook-Hee Hong, Jin Hyoung Kang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Immune checkpoint blockades (ICBs) are characterized by a durable clinical response and better tolerability in patients with a variety of advanced solid tumors. However, we not infrequently encounter patients with hyperprogressive
Externí odkaz:
https://doaj.org/article/af7c81e1bb04464fa55c054aae8776d3
Autor:
Kyu Hye Choi, Jin Ho Song, Ji Hyun Hong, Youn Soo Lee, Jin Hyoung Kang, Dong-Il Sun, Min-Sik Kim, Yeon-Sil Kim
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273059 (2022)
ObjectivesThe pathologic nodal stage of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) patients is classified according to the number of lymph nodes (LNs), as revised in 2018. Previous studies showed that the LN ratio (LNR) could be al
Externí odkaz:
https://doaj.org/article/2d00f12b532341908cf8ae0ed6e0888d
Autor:
Seo Ree Kim, Sang Hoon Chun, Ji Hyun Kim, Sang-Yeob Kim, Bo-In Lee, Chan Kwon Jung, Jin Hyoung Kang
Publikováno v:
Korean Journal of Clinical Oncology, Vol 16, Iss 1, Pp 57-62 (2020)
Recent data showed that DNA mismatch repair deficiency can be a predictive biomarker for a favorable response of immune checkpoint inhibitors regardless of tumor type due to give rise to high tumor mutational burden (TMB) and microsatellite instabili
Externí odkaz:
https://doaj.org/article/026aff21bac84bd9849f44aaab221385
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background This study aimed to assess the effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing treatment with immune checkpoint inhibitors (ICIs). Methods The medical records of 234 patients treated with I
Externí odkaz:
https://doaj.org/article/80ddc76136764276be6d3f17d908d025
Publikováno v:
Thoracic Cancer, Vol 10, Iss 7, Pp 1612-1618 (2019)
Background Although there have been several studies on concordance of different assays testing programmed cell death ligand‐1 (PD‐L1) expression using surgical specimens, studies using real‐world biopsy specimens are scarce. However, many of th
Externí odkaz:
https://doaj.org/article/cf97a302f71a447e8e5bda97d9d63ff0
Autor:
Jongmin Lee, M.B., Young Kyoon Kim, M.D., Ye Young Seo, M.B., Eun Kyoung Choi, M.D., Dong Soo Lee, M.D., Yeon Sil Kim, M.D., Sook Hee Hong, M.D., Jin Hyoung Kang, M.D., Kyo Young Lee, M.D., Jae Kil Park, M.D., Sook Whan Sung, M.D., Hyun Bin Kim, M.P.H., Mi Sun Park, M.S., Hyeon Woo Yim, M.D., Seung Joon Kim, M.D., Ph.D.
Publikováno v:
Tuberculosis and Respiratory Diseases, Vol 81, Iss 4, Pp 339-346 (2018)
Background Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a standard procedure to evaluate suspicious lymph node involvement of lung cancer because computed tomography (CT) and 18F-fluorodeoxyglucose positron emiss
Externí odkaz:
https://doaj.org/article/614a8a1cbba04320b358bf8972809512
Publikováno v:
Cancers, Vol 12, Iss 12, p 3579 (2020)
Sel-CapTM, a digital enrichment next-generation sequencing (NGS)-based cancer panel, was assessed for detection of epidermal growth factor receptor (EGFR) gene mutations in plasma for non-small cell lung cancer (NSCLC), and for application in monitor
Externí odkaz:
https://doaj.org/article/6d95f3c8c8134686bc95fe915731037a
Autor:
Jeong-Oh Kim, Jung-Young Shin, Seo Ree Kim, Kab Soo Shin, Joori Kim, Min-Young Kim, Mi-Ran Lee, Yonggoo Kim, Myungshin Kim, Sook Hee Hong, Jin Hyoung Kang
Publikováno v:
Cancers, Vol 12, Iss 4, p 785 (2020)
Epidermal growth factor receptor (EGFR) mutation testing is essential for individualized treatment using tyrosine kinase inhibitors. We evaluated two EGFR mutation tests, cobas v2 and PANAMutyper, for detection of EGFR activating mutations Ex19del, L
Externí odkaz:
https://doaj.org/article/f09d57bc55734f3cbd707443028e29ea